Indications and Purposes
| 1 Indications And Usage Inlyta Is Indicated For The Treatment Of Advanced Renal Cell Carcinoma (Rcc) After Failure Of One Prior Systemic Therapy. Inlyta Is A Kinase Inhibitor Indicated For The Treatment Of Advanced Renal Cell Carcinoma After Failure Of One Prior Systemic Therapy. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Axitinib |
|
ZINC3816287 |